263 related articles for article (PubMed ID: 28554983)
41. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced fibrotic responses in vascular smooth muscle cells.
Du CQ; Liu XW; Zeng GZ; Jin HF; Tang LJ
Int J Mol Med; 2015 Jun; 35(6):1767-72. PubMed ID: 25847782
[TBL] [Abstract][Full Text] [Related]
42. P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis.
Nishida M; Sato Y; Uemura A; Narita Y; Tozaki-Saitoh H; Nakaya M; Ide T; Suzuki K; Inoue K; Nagao T; Kurose H
EMBO J; 2008 Dec; 27(23):3104-15. PubMed ID: 19008857
[TBL] [Abstract][Full Text] [Related]
43. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
[TBL] [Abstract][Full Text] [Related]
44. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366
[TBL] [Abstract][Full Text] [Related]
45. Uncaria Rhynchophylla attenuates angiotensin Ⅱ-induced myocardial fibrosis via suppression of the RhoA/ROCK1 pathway.
Xie L; Wang T; Lin S; Lu Z; Wang Y; Shen Z; Cheng Y; Shen A; Peng J; Chu J
Biomed Pharmacother; 2022 Feb; 146():112607. PubMed ID: 35062072
[TBL] [Abstract][Full Text] [Related]
46. Angiotensin II upregulation of cardiomyocyte adiponectin production is nitric oxide/cyclic GMP dependent.
Guo B; Li Y; Han R; Zhou H; Wang M
Am J Med Sci; 2011 May; 341(5):350-5. PubMed ID: 21358315
[TBL] [Abstract][Full Text] [Related]
47. Endothelial nitric oxide synthase inhibits G12/13 and rho-kinase activated by the angiotensin II type-1 receptor: implication in vascular migration.
Suzuki H; Kimura K; Shirai H; Eguchi K; Higuchi S; Hinoki A; Ishimaru K; Brailoiu E; Dhanasekaran DN; Stemmle LN; Fields TA; Frank GD; Autieri MV; Eguchi S
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):217-24. PubMed ID: 19095998
[TBL] [Abstract][Full Text] [Related]
48. Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth.
Chen C; Wei X; Rao X; Wu J; Yang S; Chen F; Ma D; Zhou J; Dackor RT; Zeldin DC; Wang DW
J Pharmacol Exp Ther; 2011 Feb; 336(2):344-55. PubMed ID: 21030485
[TBL] [Abstract][Full Text] [Related]
49. Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes.
Aliwarga T; Evangelista EA; Sotoodehnia N; Lemaitre RN; Totah RA
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966295
[TBL] [Abstract][Full Text] [Related]
50. Carvedilol Inhibits Angiotensin II-Induced Proliferation and Contraction in Hepatic Stellate Cells through the RhoA/Rho-Kinase Pathway.
Wu Y; Li Z; Wang S; Xiu A; Zhang C
Biomed Res Int; 2019; 2019():7932046. PubMed ID: 31828132
[TBL] [Abstract][Full Text] [Related]
51. Chronic restraint stress induces changes in the cerebral Galpha 12/13 and Rho-GTPase signaling network.
Rafa-Zabłocka K; Zelek-Molik A; Tepper B; Chmielarz P; Kreiner G; Wilczkowski M; Nalepa I
Pharmacol Rep; 2021 Aug; 73(4):1179-1187. PubMed ID: 34117630
[TBL] [Abstract][Full Text] [Related]
52. G12 signaling through c-Jun NH2-terminal kinase promotes breast cancer cell invasion.
Juneja J; Cushman I; Casey PJ
PLoS One; 2011; 6(11):e26085. PubMed ID: 22087220
[TBL] [Abstract][Full Text] [Related]
53. Gα
Kim KM; Han CY; Kim JY; Cho SS; Kim YS; Koo JH; Lee JM; Lim SC; Kang KW; Kim JS; Hwang SJ; Ki SH; Kim SG
J Hepatol; 2018 Mar; 68(3):493-504. PubMed ID: 29080810
[TBL] [Abstract][Full Text] [Related]
54. CYP2J2 and EETs protect against lung ischemia/reperfusion injury via anti-inflammatory effects in vivo and in vitro.
Chen W; Yang S; Ping W; Fu X; Xu Q; Wang J
Cell Physiol Biochem; 2015; 35(5):2043-54. PubMed ID: 25870948
[TBL] [Abstract][Full Text] [Related]
55. Sildenafil Does Not Prevent Heart Hypertrophy and Fibrosis Induced by Cardiomyocyte Angiotensin II Type 1 Receptor Signaling.
Straubinger J; Schöttle V; Bork N; Subramanian H; Dünnes S; Russwurm M; Gawaz M; Friebe A; Nemer M; Nikolaev VO; Lukowski R
J Pharmacol Exp Ther; 2015 Sep; 354(3):406-16. PubMed ID: 26157043
[TBL] [Abstract][Full Text] [Related]
56. Glycogen synthase kinase-3 is activated in neuronal cells by Galpha12 and Galpha13 by Rho-independent and Rho-dependent mechanisms.
Sayas CL; Avila J; Wandosell F
J Neurosci; 2002 Aug; 22(16):6863-75. PubMed ID: 12177184
[TBL] [Abstract][Full Text] [Related]
57. CYP2J2 Overexpression Increases EETs and Protects Against HFD-Induced Atherosclerosis in ApoE-/- Mice.
Liu W; Wang T; He X; Liu X; Wang B; Liu Y; Li Z; Tan R; Ding C; Wang H; Zeng H
J Cardiovasc Pharmacol; 2016 Jun; 67(6):491-502. PubMed ID: 26859195
[TBL] [Abstract][Full Text] [Related]
58. TMEM16A contributes to angiotensin II-induced cerebral vasoconstriction via the RhoA/ROCK signaling pathway.
Li RS; Wang Y; Chen HS; Jiang FY; Tu Q; Li WJ; Yin RX
Mol Med Rep; 2016 Apr; 13(4):3691-9. PubMed ID: 26955761
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of farnesylpyrophosphate synthase prevents angiotensin II-induced hypertrophic responses in rat neonatal cardiomyocytes: involvement of the RhoA/Rho kinase pathway.
Ye Y; Hu SJ; Li L
FEBS Lett; 2009 Sep; 583(18):2997-3003. PubMed ID: 19716825
[TBL] [Abstract][Full Text] [Related]
60. Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells.
Katragadda D; Batchu SN; Cho WJ; Chaudhary KR; Falck JR; Seubert JM
J Mol Cell Cardiol; 2009 Jun; 46(6):867-75. PubMed ID: 19285984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
